AU1334799A - Novel cytokine receptors - Google Patents

Novel cytokine receptors

Info

Publication number
AU1334799A
AU1334799A AU13347/99A AU1334799A AU1334799A AU 1334799 A AU1334799 A AU 1334799A AU 13347/99 A AU13347/99 A AU 13347/99A AU 1334799 A AU1334799 A AU 1334799A AU 1334799 A AU1334799 A AU 1334799A
Authority
AU
Australia
Prior art keywords
cytokine receptors
novel cytokine
novel
receptors
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13347/99A
Inventor
Greg Elson
Jean-Francois Gauchat
Marie Kosco-Vilbois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1334799A publication Critical patent/AU1334799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13347/99A 1997-10-16 1998-10-14 Novel cytokine receptors Abandoned AU1334799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9721961.2A GB9721961D0 (en) 1997-10-16 1997-10-16 Novel molecules
GB9721961 1997-10-16
PCT/EP1998/006497 WO1999020755A2 (en) 1997-10-16 1998-10-14 Novel cytokine receptors

Publications (1)

Publication Number Publication Date
AU1334799A true AU1334799A (en) 1999-05-10

Family

ID=10820679

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13347/99A Abandoned AU1334799A (en) 1997-10-16 1998-10-14 Novel cytokine receptors

Country Status (5)

Country Link
EP (1) EP1027438A2 (en)
JP (1) JP2002508922A (en)
AU (1) AU1334799A (en)
GB (1) GB9721961D0 (en)
WO (1) WO1999020755A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035264A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation H14 dna and polypeptides
US6060276A (en) * 1998-01-22 2000-05-09 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding novel orphan cytokine receptors
NZ507293A (en) * 1998-04-10 2003-12-19 Inst Genetics Llc U4, a member of the hematopoietin receptor superfamily
US6800460B1 (en) 1999-03-11 2004-10-05 Schering Corporation Mammalian cytokine complexes
AR022890A1 (en) * 1999-03-11 2002-09-04 Schering Corp MAMMARY CYTOKINS; RELATED REAGENTS AND METHODS
EP1950299A1 (en) 1999-06-01 2008-07-30 Schering Corporation Mammalian receptor proteins; related reagents and methods
TN2017000375A1 (en) 2015-03-10 2019-01-16 Aduro Biotech Inc Compositions and methods for activating "stimulator of interferon gene" -dependent signalling
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621431D0 (en) * 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
AU2017378111A1 (en) 2016-12-16 2019-06-13 National University Of Singapore IL-11 antibodies
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
MX2021008727A (en) 2019-01-21 2021-11-04 Singapore Health Serv Pte Ltd Treatment of hepatotoxicity.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
AU718899C (en) * 1995-10-23 2004-01-29 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
JP2001508309A (en) * 1997-01-16 2001-06-26 ジェネティックス・インスチチュート・インコーポレーテッド Member of the hematopoietin receptor superfamily
AU7276098A (en) * 1997-05-01 1998-11-24 Zymogenetics Inc. Mammalian cytokine-like receptor

Also Published As

Publication number Publication date
WO1999020755A3 (en) 1999-07-29
EP1027438A2 (en) 2000-08-16
WO1999020755A2 (en) 1999-04-29
JP2002508922A (en) 2002-03-26
GB9721961D0 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
AU6535098A (en) Zcytor7 cytokine receptor
AU6873398A (en) Table construction
AU1709299A (en) Mixer-injectors
AU7966098A (en) Hm74a receptor
AU7132898A (en) Edg-1-like receptor
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU8391498A (en) Semaphorin receptors
AU1334799A (en) Novel cytokine receptors
AU5104799A (en) Novel orphan cytokine receptors
AU1535699A (en) Novel receptors opg-2
AU8165298A (en) Cardiotrophin-like cytokine
EP0903415A3 (en) Structure expansée
AU8749998A (en) Neovascularization promoters
AUPO938697A0 (en) Novel receptor
AU7165998A (en) Neurotrophic factor receptors
AU6673898A (en) Factor x variant
AU8072498A (en) Heregulin-like factor
AU7583898A (en) Gdnf receptors
AU4411699A (en) Interferon receptor hkaef92
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU3543599A (en) Receptors
AU8736698A (en) Shale-stabilizing additives
AU7539498A (en) Elevated paving structure
EP0904287A3 (en) Cytokine designated lerk-8
AU6826498A (en) Endotholin receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase